Star Combo Pharma Dividends and Buybacks
Dividend criteria checks 2/6
Star Combo Pharma is a dividend paying company with a current yield of 2.64% that is well covered by earnings.
Key information
2.6%
Dividend yield
-0.0003%
Buyback Yield
Total Shareholder Yield | 2.6% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | AU$0.0037 |
Payout ratio | 67% |
Recent dividend and buyback updates
Recent updates
There's Reason For Concern Over Star Combo Pharma Limited's (ASX:S66) Massive 30% Price Jump
Jan 05Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding
Nov 11Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up
Aug 23Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger
Aug 13Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 12Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price
May 12Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether S66's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if S66's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
Star Combo Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (S66) | 2.6% |
Market Bottom 25% (AU) | 2.6% |
Market Top 25% (AU) | 6.0% |
Industry Average (Personal Products) | 2.3% |
Analyst forecast (S66) (up to 3 years) | n/a |
Notable Dividend: S66's dividend (2.64%) is higher than the bottom 25% of dividend payers in the Australian market (2.64%).
High Dividend: S66's dividend (2.64%) is low compared to the top 25% of dividend payers in the Australian market (6.03%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (66.9%), S66's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: S66 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/26 07:29 |
End of Day Share Price | 2025/01/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|